Cargando…
Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients
The current inability of psychiatric medicine to objectively select the most appropriate treatment or to predict imminent relapse are major factors contributing to the severity and clinical burden of schizophrenia. We have previously used multiplexed immunoassays to show that schizophrenia patients...
Autores principales: | Schwarz, E, Guest, P C, Steiner, J, Bogerts, B, Bahn, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309553/ https://www.ncbi.nlm.nih.gov/pubmed/22832819 http://dx.doi.org/10.1038/tp.2012.3 |
Ejemplares similares
-
Distinct Molecular Phenotypes in Male and Female Schizophrenia Patients
por: Ramsey, Jordan M., et al.
Publicado: (2013) -
Validation of a Blood-Based Laboratory Test to Aid in the Confirmation of a Diagnosis of Schizophrenia
por: Schwarz, Emanuel, et al.
Publicado: (2010) -
Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset
por: Chan, M K, et al.
Publicado: (2015) -
Molecular Sex Differences in Human Serum
por: Ramsey, Jordan M., et al.
Publicado: (2012) -
Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment
por: Steiner, Johann, et al.
Publicado: (2020)